GenixPharmaceucticals Corporation (GENX) — Cash Flow-to-Debt Ratio
GenixPharmaceucticals Corporation (GENX) has a Cash Flow-to-Debt Ratio of -0.01x as of April 2026, meaning its operating cash flow of CA$-16.30K could theoretically repay 0% of its total liabilities (CA$1.58 Million) in one year. Check GENX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GenixPharmaceucticals Corporation Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for GenixPharmaceucticals Corporation across 11 annual periods. Also explore how large is GenixPharmaceucticals Corporation's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GenixPharmaceucticals Corporation (2015–2025)
Year-by-year debt coverage analysis for GenixPharmaceucticals Corporation. For market capitalisation and broader financial context, see GENX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | CA$-124.07K | CA$1.47 Million | ▲ +44.7% |
| 2024 | -0.15x | CA$-187.34K | CA$1.23 Million | ▲ +6.0% |
| 2023 | -0.16x | CA$-220.67K | CA$1.36 Million | ▲ +22.2% |
| 2022 | -0.21x | CA$-219.58K | CA$1.05 Million | ▲ +63.3% |
| 2021 | -0.57x | CA$-428.31K | CA$755.19K | ▼ -42.5% |
| 2020 | -0.40x | CA$-195.03K | CA$489.88K | ▲ +44.0% |
| 2019 | -0.71x | CA$-58.55K | CA$82.41K | ▼ -326.9% |
| 2018 | 0.31x | CA$34.18K | CA$109.15K | ▲ +1013.5% |
| 2017 | -0.03x | CA$-9.35K | CA$272.80K | ▲ +98.6% |
| 2016 | -2.43x | CA$-165.07K | CA$68.04K | ▲ +40.6% |
| 2015 | -4.09x | CA$-452.55K | CA$110.78K | — |